anti-PD-L1 monoclonal antibody (Iontas)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-PD-L1 monoclonal antibody (Iontas)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIontas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIontas
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A